de Jong EC - Search Results

1

Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity.

Vogelpoel LT, Baeten DL, de Jong EC, den Dunnen J. Vogelpoel LT, et al. Among authors: de jong ec. Front Immunol. 2015 Feb 24;6:79. doi: 10.3389/fimmu.2015.00079. eCollection 2015. Front Immunol. 2015. PMID: 25759693 Free PMC article. Review.

2

Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential.

Vieira PL, Kaliński P, Wierenga EA, Kapsenberg ML, de Jong EC. Vieira PL, et al. Among authors: de jong ec. J Immunol. 1998 Nov 15;161(10):5245-51. J Immunol. 1998. PMID: 9820496

3

The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5.

van der Veen MJ, Van Neerven RJ, De Jong EC, Aalberse RC, Jansen HM, van der Zee JS. van der Veen MJ, et al. Among authors: de jong ec. Clin Exp Allergy. 1999 Feb;29(2):217-27. doi: 10.1046/j.1365-2222.1999.00466.x. Clin Exp Allergy. 1999. PMID: 10051726

4

Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction.

Vieira PL, de Jong EC, Wierenga EA, Kapsenberg ML, Kaliński P. Vieira PL, et al. Among authors: de jong ec. J Immunol. 2000 May 1;164(9):4507-12. doi: 10.4049/jimmunol.164.9.4507. J Immunol. 2000. PMID: 10779751

5

IL-4 is a mediator of IL-12p70 induction by human Th2 cells: reversal of polarized Th2 phenotype by dendritic cells.

Kaliński P, Smits HH, Schuitemaker JH, Vieira PL, van Eijk M, de Jong EC, Wierenga EA, Kapsenberg ML. Kaliński P, et al. Among authors: de jong ec. J Immunol. 2000 Aug 15;165(4):1877-81. doi: 10.4049/jimmunol.165.4.1877. J Immunol. 2000. PMID: 10925267

6

Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals.

de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, Yazdanbakhsh M, Kapsenberg ML. de Jong EC, et al. J Immunol. 2002 Feb 15;168(4):1704-9. doi: 10.4049/jimmunol.168.4.1704. J Immunol. 2002. PMID: 11823500

7

Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development.

Smits HH, de Jong EC, Schuitemaker JH, Geijtenbeek TB, van Kooyk Y, Kapsenberg ML, Wierenga EA. Smits HH, et al. Among authors: de jong ec. J Immunol. 2002 Feb 15;168(4):1710-6. doi: 10.4049/jimmunol.168.4.1710. J Immunol. 2002. PMID: 11823501

8

Inactivation of the EGF-TM7 receptor EMR4 after the Pan-Homo divergence.

Hamann J, Kwakkenbos MJ, de Jong EC, Heus H, Olsen AS, van Lier RA. Hamann J, et al. Among authors: de jong ec. Eur J Immunol. 2003 May;33(5):1365-71. doi: 10.1002/eji.200323881. Eur J Immunol. 2003. PMID: 12731063

9

Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarized phenotype in dendritic cells: role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18.

Lebre MC, Antons JC, Kalinski P, Schuitemaker JH, van Capel TM, Kapsenberg ML, De Jong EC. Lebre MC, et al. Among authors: de jong ec. J Invest Dermatol. 2003 Jun;120(6):990-7. doi: 10.1046/j.1523-1747.2003.12245.x. J Invest Dermatol. 2003. PMID: 12787126

10

Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFN-gamma-mediated signaling.

Heystek HC, den Drijver B, Kapsenberg ML, van Lier RA, de Jong EC. Heystek HC, et al. Among authors: de jong ec. Clin Immunol. 2003 Jun;107(3):170-7. doi: 10.1016/s1521-6616(03)00060-3. Clin Immunol. 2003. PMID: 12804530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results